Poland Cold Chain & Pharma Logistics Market

Poland Cold Chain & Pharma Logistics Market, valued at USD 3 billion, is growing due to rising demand for chilled pharmaceuticals, e-commerce expansion, and tech innovations like IoT monitoring.

Region:Europe

Author(s):Shubham

Product Code:KRAB1154

Pages:85

Published On:October 2025

About the Report

Base Year 2024

Poland Cold Chain & Pharma Logistics Market Overview

  • The Poland Cold Chain & Pharma Logistics Market is valued at USD 3 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for temperature-sensitive products, particularly in the pharmaceutical and food sectors, alongside the expansion of e-commerce and online grocery shopping. The rising awareness of health and safety standards has also contributed to the market's growth, as companies invest in advanced cold chain solutions to ensure product integrity.
  • Key cities such as Warsaw, Kraków, and Wroc?aw dominate the market due to their strategic locations, robust infrastructure, and proximity to major transportation hubs. These cities serve as logistical centers that facilitate efficient distribution networks, making them attractive for both domestic and international companies looking to optimize their supply chains in the cold chain and pharma logistics sectors.
  • In Poland, the Good Distribution Practice (GDP) regulations are crucial for pharmaceutical logistics, ensuring that all temperature-sensitive products are stored and transported under controlled conditions. Compliance with these regulations is essential for maintaining the safety and efficacy of pharmaceuticals throughout the supply chain.
Poland Cold Chain & Pharma Logistics Market Size

Poland Cold Chain & Pharma Logistics Market Segmentation

By Service Type:The service type segmentation includes various subsegments such as Storage (Cold Warehousing), Transportation (Refrigerated Road, Rail, Air, Sea), Value-Added Services (Packaging, Labelling, Inventory Management), Temperature Monitoring & Tracking Systems, and Others. Among these, Transportation is the leading subsegment due to the increasing demand for efficient and reliable delivery of temperature-sensitive goods across various regions. The rise of e-commerce has further fueled the need for advanced transportation solutions that ensure product integrity during transit.

Poland Cold Chain & Pharma Logistics Market segmentation by Service Type.

By Temperature Range:The temperature range segmentation includes Chilled (2°C to 8°C), Frozen (Below -18°C), Ambient (15°C to 25°C), and Others. The Chilled segment is the most significant due to the high demand for pharmaceuticals and perishable food items that require strict temperature control. The growing consumer preference for fresh produce and the need for effective vaccine distribution have further solidified the importance of this segment in the cold chain logistics market.

Poland Cold Chain & Pharma Logistics Market segmentation by Temperature Range.

Poland Cold Chain & Pharma Logistics Market Competitive Landscape

The Poland Cold Chain & Pharma Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Frigo Logistics, Green Yard Logistics, Pago Logistics, Uni Logistics, DB Schenker, Kuehne + Nagel, DSV, DHL Supply Chain, Geodis, UPS Healthcare, FedEx, NewCold, Raben Group, Rohlig Suus Logistics, FM Logistic contribute to innovation, geographic expansion, and service delivery in this space.

Frigo Logistics

2005

Warsaw, Poland

Green Yard Logistics

2010

Kraków, Poland

Pago Logistics

2000

Wroc?aw, Poland

Uni Logistics

2015

Gda?sk, Poland

DB Schenker

1872

Berlin, Germany

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (YoY %)

Market Share (%)

Geographic Coverage (National, Regional, International)

Fleet Size & Cold Storage Capacity

Compliance Rate with GDP/GMP/ISO Standards

Poland Cold Chain & Pharma Logistics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Sensitive Pharmaceuticals:The Polish pharmaceutical market is projected to reach €12 billion in the future, driven by a surge in demand for temperature-sensitive products. With over 40% of pharmaceuticals requiring cold chain logistics, the need for reliable transportation and storage solutions is critical. The rise in chronic diseases and an aging population, which is expected to reach 25% of the total population in the future, further fuels this demand, necessitating robust cold chain systems.
  • Expansion of E-commerce in the Pharmaceutical Sector:E-commerce sales in Poland's pharmaceutical sector are anticipated to exceed €1.5 billion in the future, reflecting a significant shift in consumer purchasing behavior. This growth is supported by the increasing adoption of online pharmacies, which require efficient cold chain logistics to ensure product integrity. The convenience of home delivery and the rise of telemedicine are also contributing factors, creating a pressing need for temperature-controlled logistics solutions.
  • Government Initiatives to Enhance Healthcare Logistics:The Polish government has allocated €500 million for healthcare infrastructure improvements, including cold chain logistics, as part of its future healthcare strategy. This investment aims to modernize logistics systems, ensuring compliance with EU regulations and improving access to temperature-sensitive medications. Enhanced logistics capabilities are expected to streamline distribution channels, ultimately improving patient outcomes and supporting the growing pharmaceutical market.

Market Challenges

  • High Operational Costs Associated with Cold Chain Logistics:The operational costs for cold chain logistics in Poland are estimated to be around €1.2 billion annually, primarily due to energy expenses and specialized equipment requirements. These high costs can deter smaller logistics providers from entering the market, limiting competition and innovation. Additionally, the need for continuous temperature monitoring and compliance with stringent regulations adds to the financial burden on logistics companies.
  • Regulatory Compliance Complexities:Navigating the regulatory landscape in Poland can be challenging for cold chain logistics providers. Compliance with EU Good Distribution Practice (GDP) and local regulations requires significant investment in training and infrastructure. The complexity of these regulations can lead to delays and increased costs, with non-compliance potentially resulting in fines exceeding €100,000. This regulatory burden can hinder market entry for new players and stifle growth for existing companies.

Poland Cold Chain & Pharma Logistics Market Future Outlook

The future of the cold chain and pharma logistics market in Poland appears promising, driven by technological advancements and increasing demand for biopharmaceuticals. The integration of IoT for real-time tracking and monitoring is expected to enhance operational efficiency and compliance. Additionally, the focus on sustainability will likely lead to the adoption of eco-friendly practices, further shaping the logistics landscape. As the market evolves, companies that adapt to these trends will be well-positioned for growth and success.

Market Opportunities

  • Technological Advancements in Temperature Monitoring:The adoption of advanced temperature monitoring technologies, such as IoT sensors, presents a significant opportunity for logistics providers. These innovations can enhance real-time tracking capabilities, ensuring compliance with regulatory standards and improving product safety. The market for temperature monitoring solutions is projected to grow by €200 million in the future, reflecting the increasing importance of data-driven logistics.
  • Growth in Biopharmaceuticals Requiring Specialized Logistics:The biopharmaceutical sector in Poland is expected to grow to €3 billion in the future, creating a demand for specialized logistics solutions. This growth presents an opportunity for logistics providers to develop tailored services that meet the unique requirements of biopharmaceuticals, including temperature control and secure transportation. Companies that invest in these specialized services can capture a significant share of this expanding market.

Scope of the Report

SegmentSub-Segments
By Service Type

Storage (Cold Warehousing)

Transportation (Refrigerated Road, Rail, Air, Sea)

Value-Added Services (Packaging, Labelling, Inventory Management)

Temperature Monitoring & Tracking Systems

Others

By Temperature Range

Chilled (2°C to 8°C)

Frozen (Below -18°C)

Ambient (15°C to 25°C)

Others

By End-User Industry

Pharmaceuticals

Life Sciences & Biotech

Horticulture (Fresh Fruits & Vegetables)

Dairy Products

Meat, Fish, Poultry

Processed Food Products

Chemicals

Others

By Packaging Type

Insulated Containers

Refrigerated Trucks & Trailers

Active & Passive Packaging Solutions

Others

By Distribution Mode

Direct Distribution

Third-Party Logistics (3PL)

E-commerce Platforms

Others

By Application

Vaccines

Blood Products

Biologics

Clinical Trials

Others

By Regulatory Compliance

EU Regulations (GDP, GMP)

National Standards

Industry Certifications (ISO, HACCP)

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Polish Pharmaceutical Chamber, Office for Registration of Medicinal Products)

Pharmaceutical Manufacturers

Cold Chain Logistics Providers

Healthcare Providers and Hospitals

Biotechnology Companies

Pharmaceutical Wholesalers

Logistics Technology Solution Providers

Players Mentioned in the Report:

Frigo Logistics

Green Yard Logistics

Pago Logistics

Uni Logistics

DB Schenker

Kuehne + Nagel

DSV

DHL Supply Chain

Geodis

UPS Healthcare

FedEx

NewCold

Raben Group

Rohlig Suus Logistics

FM Logistic

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Poland Cold Chain & Pharma Logistics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Poland Cold Chain & Pharma Logistics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Poland Cold Chain & Pharma Logistics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for temperature-sensitive pharmaceuticals
3.1.2 Expansion of e-commerce in the pharmaceutical sector
3.1.3 Government initiatives to enhance healthcare logistics
3.1.4 Rising consumer awareness regarding drug safety

3.2 Market Challenges

3.2.1 High operational costs associated with cold chain logistics
3.2.2 Regulatory compliance complexities
3.2.3 Limited infrastructure in rural areas
3.2.4 Competition from alternative logistics solutions

3.3 Market Opportunities

3.3.1 Technological advancements in temperature monitoring
3.3.2 Growth in biopharmaceuticals requiring specialized logistics
3.3.3 Partnerships with local healthcare providers
3.3.4 Expansion into underserved regions

3.4 Market Trends

3.4.1 Adoption of IoT for real-time tracking
3.4.2 Increasing focus on sustainability in logistics
3.4.3 Shift towards automated warehousing solutions
3.4.4 Rise of third-party logistics providers

3.5 Government Regulation

3.5.1 Compliance with EU Good Distribution Practice (GDP)
3.5.2 Regulations on temperature control for pharmaceuticals
3.5.3 Licensing requirements for cold storage facilities
3.5.4 Standards for transportation of hazardous materials

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Poland Cold Chain & Pharma Logistics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Poland Cold Chain & Pharma Logistics Market Segmentation

8.1 By Service Type

8.1.1 Storage (Cold Warehousing)
8.1.2 Transportation (Refrigerated Road, Rail, Air, Sea)
8.1.3 Value-Added Services (Packaging, Labelling, Inventory Management)
8.1.4 Temperature Monitoring & Tracking Systems
8.1.5 Others

8.2 By Temperature Range

8.2.1 Chilled (2°C to 8°C)
8.2.2 Frozen (Below -18°C)
8.2.3 Ambient (15°C to 25°C)
8.2.4 Others

8.3 By End-User Industry

8.3.1 Pharmaceuticals
8.3.2 Life Sciences & Biotech
8.3.3 Horticulture (Fresh Fruits & Vegetables)
8.3.4 Dairy Products
8.3.5 Meat, Fish, Poultry
8.3.6 Processed Food Products
8.3.7 Chemicals
8.3.8 Others

8.4 By Packaging Type

8.4.1 Insulated Containers
8.4.2 Refrigerated Trucks & Trailers
8.4.3 Active & Passive Packaging Solutions
8.4.4 Others

8.5 By Distribution Mode

8.5.1 Direct Distribution
8.5.2 Third-Party Logistics (3PL)
8.5.3 E-commerce Platforms
8.5.4 Others

8.6 By Application

8.6.1 Vaccines
8.6.2 Blood Products
8.6.3 Biologics
8.6.4 Clinical Trials
8.6.5 Others

8.7 By Regulatory Compliance

8.7.1 EU Regulations (GDP, GMP)
8.7.2 National Standards
8.7.3 Industry Certifications (ISO, HACCP)
8.7.4 Others

9. Poland Cold Chain & Pharma Logistics Market Competitive Analysis

9.1 Market Share of Key Players(Micro, Small, Medium, Large Enterprises)

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (YoY %)
9.2.4 Market Share (%)
9.2.5 Geographic Coverage (National, Regional, International)
9.2.6 Fleet Size & Cold Storage Capacity
9.2.7 Compliance Rate with GDP/GMP/ISO Standards
9.2.8 Technology Adoption (IoT, Real-Time Monitoring, Automation)
9.2.9 Service Portfolio Breadth (Transportation, Storage, Value-Added)
9.2.10 Customer Segments Served (Pharma, Food, Biotech, etc.)
9.2.11 Supply Chain Responsiveness (Delivery Lead Time, On-Time Performance)
9.2.12 Sustainability Initiatives (Energy Efficiency, Green Logistics)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis(By Class and Payload)

9.5 Detailed Profile of Major Companies

9.5.1 Frigo Logistics
9.5.2 Green Yard Logistics
9.5.3 Pago Logistics
9.5.4 Uni Logistics
9.5.5 DB Schenker
9.5.6 Kuehne + Nagel
9.5.7 DSV
9.5.8 DHL Supply Chain
9.5.9 Geodis
9.5.10 UPS Healthcare
9.5.11 FedEx
9.5.12 NewCold
9.5.13 Raben Group
9.5.14 Rohlig Suus Logistics
9.5.15 FM Logistic

10. Poland Cold Chain & Pharma Logistics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Finance
10.1.3 Ministry of Economic Development

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Cold Storage Facilities
10.2.2 Budget Allocation for Transportation
10.2.3 Expenditure on Technology Upgrades

10.3 Pain Point Analysis by End-User Category

10.3.1 Pharmaceutical Manufacturers
10.3.2 Hospitals and Clinics
10.3.3 Retail Pharmacies

10.4 User Readiness for Adoption

10.4.1 Awareness of Cold Chain Importance
10.4.2 Training and Skill Development
10.4.3 Infrastructure Readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Cost Savings
10.5.2 Expansion into New Markets
10.5.3 Improvement in Service Delivery

11. Poland Cold Chain & Pharma Logistics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams Analysis

1.4 Cost Structure Evaluation

1.5 Key Partnerships Exploration

1.6 Customer Segmentation

1.7 Channels of Distribution


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Solutions

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model Evaluation


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership Considerations

12.2 Partnerships Evaluation


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability Strategies


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from Polish logistics associations and pharmaceutical bodies
  • Review of government publications on cold chain regulations and compliance standards
  • Examination of market trends through academic journals and white papers on logistics and supply chain management

Primary Research

  • Interviews with logistics managers at major pharmaceutical companies operating in Poland
  • Surveys with cold chain service providers to gather insights on operational challenges and innovations
  • Field interviews with regulatory experts to understand compliance requirements in the pharmaceutical sector

Validation & Triangulation

  • Cross-validation of data through multiple sources including trade publications and industry surveys
  • Triangulation of findings from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel discussions with industry veterans

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the overall cold chain logistics market size based on national pharmaceutical sales data
  • Segmentation of the market by temperature-controlled product categories and distribution channels
  • Incorporation of growth rates from government forecasts on pharmaceutical market expansion

Bottom-up Modeling

  • Collection of operational data from leading cold chain logistics providers in Poland
  • Estimation of costs associated with temperature-controlled storage and transportation
  • Volume and cost analysis based on service offerings and client contracts in the pharmaceutical sector

Forecasting & Scenario Analysis

  • Multi-variable regression analysis incorporating factors such as healthcare spending and population growth
  • Scenario modeling based on potential regulatory changes and technological advancements in logistics
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Distribution Logistics120Logistics Managers, Supply Chain Executives
Cold Chain Technology Providers80Product Development Managers, Technical Directors
Regulatory Compliance in Pharma Logistics60Compliance Officers, Quality Assurance Managers
Healthcare Sector Cold Chain Needs50Pharmacy Managers, Hospital Supply Chain Coordinators
Market Trends in Cold Chain Logistics70Market Analysts, Business Development Managers

Frequently Asked Questions

What is the current value of the Poland Cold Chain & Pharma Logistics Market?

The Poland Cold Chain & Pharma Logistics Market is valued at approximately USD 3 billion, driven by the increasing demand for temperature-sensitive products in the pharmaceutical and food sectors, as well as the growth of e-commerce and online grocery shopping.

Which cities are key players in the Poland Cold Chain & Pharma Logistics Market?

What regulations govern pharmaceutical logistics in Poland?

What are the main service types in the Poland Cold Chain & Pharma Logistics Market?

Other Adjacent Reports

Bahrain Pharmaceutical Distribution Market

South Africa Biopharmaceutical Logistics Market

Belgium Food Cold Chain Market

UAE Healthcare Supply Chain Market

Malaysia Temperature-Controlled Packaging Market

Brazil Refrigerated Transportation Market

Brazil Warehouse Management Systems Market

KSA Temperature Monitoring Devices Market

Egypt E-commerce Logistics Market

UAE Vaccine Distribution Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022